期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
基于药对探讨中药复方越鞠丸抗抑郁作用配伍规律 被引量:19
1
作者 陶伟伟 肖东 +4 位作者 吴浩然 沈佳丽 黄晓燕 薛文达 陈刚 《中国药理学通报》 CAS CSCD 北大核心 2018年第9期1314-1320,共7页
目的以药对研究为切入点,开展中药复方越鞠丸抗抑郁作用配伍规律。方法在中药复方越鞠丸抗抑郁作用的研究基础上,通过依次拆方获得不同中药药对组合,并通过小鼠急性给药获得越鞠丸中具有抗抑郁作用的关键药对;建立慢性温和不可预知性刺... 目的以药对研究为切入点,开展中药复方越鞠丸抗抑郁作用配伍规律。方法在中药复方越鞠丸抗抑郁作用的研究基础上,通过依次拆方获得不同中药药对组合,并通过小鼠急性给药获得越鞠丸中具有抗抑郁作用的关键药对;建立慢性温和不可预知性刺激小鼠模型,进一步验证关键药对的抗抑郁作用,并探讨其分子机制。结果小鼠急性给药结果表明,栀子与川芎组合为其中发挥抗抑郁作用的关键药对;在慢性温和不可预知性刺激小鼠模型中,栀子与川芎药对组小鼠糖水消耗明显升高;悬尾实验及强迫游泳实验的不动时间明显降低;小鼠海马组织中炎症因子IL-6、TNF-α的水平以及相关炎症蛋白p-NF-κB p65、p-IκBα的表达受到抑制,BDNF、TrkB蛋白表达水平明显上调。结论栀子-川芎组合为越鞠丸发挥抗抑郁作用的关键药对,该药对可以显著降低栀子产生抗抑郁作用所需剂量,且该作用与其调节小鼠海马组织中炎症因子IL-6、TNF-α与相关炎症蛋白p-NF-κB p65、p-IκBα,以及BDNF及其受体TrkB的表达有关。 展开更多
关键词 越鞠丸 抗抑郁 栀子-川芎药对 慢性温和不可预见性刺激 免疫印迹法 脑源性神经营养因子
下载PDF
Effects of Zhizi Chuanxiong Capsule (栀子川芎胶囊) on Abnormal Methylation in Rabbits with Atherosclerosis 被引量:15
2
作者 ZHOU Qing-bing WU Li-qi +2 位作者 ZHANG Yin ZHANG Zhi-fang XU Feng-qin 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2018年第7期512-517,共6页
Objective: To investigate the effects of Zhizi Chuanxiong Capsule(ZCC, 栀子川芎胶囊) on abnormal DNA methylation in a rabbit model of atherosclerosis(AS). Methods: After 1 week of adaptive feeding, 48 New Zealan... Objective: To investigate the effects of Zhizi Chuanxiong Capsule(ZCC, 栀子川芎胶囊) on abnormal DNA methylation in a rabbit model of atherosclerosis(AS). Methods: After 1 week of adaptive feeding, 48 New Zealand white rabbits were randomly divided into 4 groups: a control group(n=12) fed with normal diet for 22 weeks; a model group(n=12) fed with high fat diet for 14 weeks followed by 8 weeks of normal diet feeding; a low-dose ZCC group(n=12) fed with high fat diet and low-dose ZCC for 14 weeks, followed by 8 weeks of normal diet and low-dose drug; a high-dose ZCC group(n=12) fed with high fat diet and high-dose drug for 14 weeks, followed by 8 weeks of normal diet and high-dose drug. After 22 weeks of feeding, blood samples were taken from the rabbit ear vein, and the genomic DNA was extracted for methylation immunoprecipitation sequencing(Medip-seq). The aorta tissues were collected for hematoxylin-eosin(HE) staining. Results: Eight rabbits died during the feeding process. HE staining showed that the size of the lipid deposition on vessel wall and atherosclerotic plaque formation were reduced in both low-and high-dose group. The Medip-seq results showed that there were 146 abnormally methylated genes(including both hypermethylated gene and hypomethylated genes) in the model group, compared with the control group. Gene Ontology(GO) and Pathway analysis showed that these abnormally methylated genes were found to be involved in multiple AS-related functions and pathways, such as protein kinase C activity, cholesterol transport, mitogen-activated protein kinase(MAPK) signaling pathway, peroxisome proliferater-activated receptor signaling pathway, vascular smooth muscle contraction, inflammation and so on. The abnormal methylated genes in AS model group were altered in both low-and high-dose groups: low-dose ZCC could change 72 of the 146 abnormally methylated genes, highdose ZCC could change 71. Through GO and Pathway analysis, these altered methylated ge 展开更多
关键词 detoxifying and activating blood circulation ATHEROSCLEROSIS METHYLATION stasis and toxin zhizi chuanxiong capsule
原文传递
基于网络药理学探究栀子川芎胶囊防治动脉粥样硬化的作用机制 被引量:2
3
作者 吴立旗 盛松 +1 位作者 周庆兵 徐凤芹 《中西医结合心脑血管病杂志》 2023年第14期2513-2522,共10页
目的:采用网络药理学、基因芯片分子对接方法探讨栀子川芎胶囊防治动脉粥样硬化(AS)的作用机制。方法:利用14个数据库和基因芯片等预测栀子川芎胶囊防治AS的靶点,构建成分-治疗靶点(C-T)网络、治疗靶点网络(T-D),并计算网络贡献指数、... 目的:采用网络药理学、基因芯片分子对接方法探讨栀子川芎胶囊防治动脉粥样硬化(AS)的作用机制。方法:利用14个数据库和基因芯片等预测栀子川芎胶囊防治AS的靶点,构建成分-治疗靶点(C-T)网络、治疗靶点网络(T-D),并计算网络贡献指数、度值、中介中心性、接近中心性和平均最短路径筛选C-T和T-D网络主要核心成分和靶点。对治疗靶点进行富集分析,最后对核心成分和核心靶点做分子对接验证。结果:预测得到治疗靶点162个,根据网络贡献指数、度值、中介中心性、接近中心性和平均最短路径筛选C-T和T-D网络得到叶酸和槲皮素2个核心成分、13个核心靶点。富集分析显示栀子川芎胶囊从炎症反应、氧化应激、脂质和营养物质代谢等多方面防治AS,并且治疗靶点富集于全身多个组织器官。分子对接验证结果表明核心成分与核心靶点间具有较强的结合力。结论:栀子川芎胶囊防治AS具有多成分、多靶点的特点,可以从多层次、多角度防治AS。 展开更多
关键词 动脉粥样硬化 栀子川芎胶囊 网络药理学 基因芯片 分子对接 靶点 富集分析
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部